Evolution of HIV incubation times in AIDS patients

Y Román-Montoya1, A Bueno-Cavanillas, A M Lara-Porras

  • 1Statistics and Operational Research, University of Granada, Campus de Fuentenueva, Spain. yroman@ugr.es

AIDS Care
|December 19, 2012
PubMed

Insights

Highly active antiretroviral therapy (HAART) has reduced AIDS incidence. This study analyzed AIDS incubation times in Spain, finding longer incubation periods for women and intravenous drug users (IDU), associated with better survival outcomes.

Area of Science:

  • Epidemiology
  • Public Health
  • Virology

Background:

  • The incidence of Human Immunodeficiency Virus (HIV) infection remains largely unknown despite the decline in Acquired Immunodeficiency Syndrome (AIDS) cases due to highly active antiretroviral therapy (HAART).
  • Understanding HIV incubation periods is crucial for public health interventions and patient management.

Purpose of the Study:

  • To analyze AIDS incubation times in a large patient cohort within Spain's public health system.
  • To investigate the evolution of mean incubation times based on transmission categories and demographic factors.

Main Methods:

  • Analysis of 10,571 patient records from the Andalusian Register of Cases of AIDS (January 1981 to June 2008).
  • Utilized survival and risk function analyses with R survival and DTDA libraries to determine AIDS incubation periods.
  • Examined incubation time trends across different transmission routes (e.g., heterosexual, intravenous drug use) and demographic variables.

Main Results:

  • A growing trend in mean viral incubation times was observed over the study period.
  • Incubation periods were notably longer for women in heterosexual transmission cases.
  • Intravenous drug users (IDU) exhibited the longest incubation periods.
  • Both female gender and IDU transmission were linked to significantly greater survival without AIDS.
  • Heterosexual transmission and pneumonia diagnosis were associated with reduced survival without AIDS.

Conclusions:

  • AIDS incubation periods have evolved, with longer times observed in specific populations like women and IDUs.
  • Transmission routes and co-diagnoses significantly impact both incubation duration and survival outcomes in HIV-infected individuals.
  • Findings highlight the need for tailored public health strategies considering transmission dynamics and patient demographics.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...